The Benefits of Instant-Release Color-Coating Systems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Benefits of Instant-Release Color-Coating Systems
The author discusses a new fillm-coating system to create customized colors and the research an development tools used in conjunction with this system. This article is part of a special supplement on Excipients and Solid Dosage.


Pharmaceutical Technology
Issue 34, pp. s20-s22

A key element to this process is the spray-dry technology that produces the pigment–polymer solid dispersion. This process (Xfast, BASF) provides high surface area, solid-dispersion granules consisting of pigment embedded in the coating polymer matrix. These properties of the solid-dispersion granules, combined with the high water solubility of the polyvinyl alcohol–polyethylene glycol copolymer, allow for the fast redispersion into water. Once dispersed using a standard propeller mixer, the coating-systems' coating suspensions are ready to be used in the film-coating process in approximately 20 min.

The Kollicoat IR copolymer offers additional benefits in film-coating applications. The low viscosity, water-soluble copolymer of polyvinyl alcohol and polyethylene glycol provides color film-coatings that exhibit high elasticity. Elasticity is important when dealing with applications where a more flexible film coating is needed to eliminate film cracking that can result when using more brittle coating ingredients. The copolymer's low viscosity allows for increased manufacturing productivity by using high solids-content suspensions of 20% and higher. The adhesive properties of the polyvinyl alcohol–polyethylene glycol copolymer result in film-coated tablets with excellent logo definition. The copolymer also is internally plasticized, which eliminates the potential for plasticizer migration.

Color selection. The color system (Kollicoat IR Coating System, BASF) uses 102 preformulated color options (Color Fan, BASF). A color–combination formula is provided for each color square. As a result, film-coating formulation–development work is not necessary, and color evaluation on a solid oral-dosage form can be completed using the preformulated formulation.

An important part of the color system is the software, which is used to expand the color options by using preformulated recipes to create new colors by adjusting the amounts of base global colors found in a given formulation. For example, a preformulated color can be made lighter or darker by either increasing or decreasing the percentage of one of the formula components, or a wholly new color can be created by adding a new color component or removing one from the original formula. The new color is displayed as a color square on a computer monitor, and the resulting formula can be evaluated in the laboratory either by film casting or coating a tablet.

Alternative color measurement . A color-measurement spectrophotometer can be used to measure the color of another product, a tablet or capsule, for example, in order to match that color. The CIE color scale can be used to generate L*a*b* color values, which define color in a color space. The L* axis represents the color scale from black to white, and the a* and b* axes represent color values from green to red and blue to yellow, respectively. The L*a*b* color values generated are used by the software to provide the closet color match. Manual pigment manipulation and combination are not needed to determine a specific color match. The software provides a measured starting point based on the combination of formulations in the coating system.

Regulatory considerations. The software can provide regulatory guidance for products marketed in the United States, European Union, and Japan with regards to pigment levels on a final dosage form. By factoring in tablet dimensions, specific coating weight gain, colorant concentrations, and daily product dosing, the software determines whether a specific coating formulation exceeds current colorant limits in the US, the EU, and Japan. Using this regulatory software tool, a color formulation can be created and evaluated without having to prepare a test formulation or perform a coating trial. If a specific coating-formulation color exceeds colorant limits, the formulation and color can be adjusted using the software before actual color-coating work is completed in the laboratory.

Conclusion

The application of the new color system (Kollicoat IR coating system) illustrates how pharmaceutical excipient technologies can be combined to make new color options for immediate-release film coatings. The system also is a good tool to increase productivity and reduce the development time encountered in manual color systems.

Phil Butler is a technical sales manager for BASF, 100 Campus Drive, Florham Park, NJ 07932, tel. 973.245.6378, fax. 973.245.6843,
.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here